226 related articles for article (PubMed ID: 32859258)
1. Sex differences in brain atrophy in multiple sclerosis.
Voskuhl RR; Patel K; Paul F; Gold SM; Scheel M; Kuchling J; Cooper G; Asseyer S; Chien C; Brandt AU; Meyer CE; MacKenzie-Graham A
Biol Sex Differ; 2020 Aug; 11(1):49. PubMed ID: 32859258
[TBL] [Abstract][Full Text] [Related]
2. Detection and quantification of regional cortical gray matter damage in multiple sclerosis utilizing gradient echo MRI.
Wen J; Yablonskiy DA; Luo J; Lancia S; Hildebolt C; Cross AH
Neuroimage Clin; 2015; 9():164-75. PubMed ID: 27330979
[TBL] [Abstract][Full Text] [Related]
3. Evidence of thalamic gray matter loss in pediatric multiple sclerosis.
Mesaros S; Rocca MA; Absinta M; Ghezzi A; Milani N; Moiola L; Veggiotti P; Comi G; Filippi M
Neurology; 2008 Mar; 70(13 Pt 2):1107-12. PubMed ID: 18272867
[TBL] [Abstract][Full Text] [Related]
4. Gray matter trophism, cognitive impairment, and depression in patients with multiple sclerosis.
Pravatà E; Rocca MA; Valsasina P; Riccitelli GC; Gobbi C; Comi G; Falini A; Filippi M
Mult Scler; 2017 Dec; 23(14):1864-1874. PubMed ID: 28169581
[TBL] [Abstract][Full Text] [Related]
5. Are Cerebral Perfusion and Atrophy Linked in Multiple Sclerosis? Evidence for a Multifactorial Approach to Assess Neurodegeneration.
Laganá MM; Mendozzi L; Pelizzari L; Bergsland NP; Pugnetti L; Cecconi P; Baselli G; Clerici M; Nemni R; Baglio F
Curr Neurovasc Res; 2018; 15(4):282-291. PubMed ID: 30468125
[TBL] [Abstract][Full Text] [Related]
6. Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis.
Battaglini M; Giorgio A; Stromillo ML; Bartolozzi ML; Guidi L; Federico A; De Stefano N
J Neurol Sci; 2009 Jul; 282(1-2):55-60. PubMed ID: 19286193
[TBL] [Abstract][Full Text] [Related]
7. Exploration of the relationships between regional grey matter atrophy and cognition in multiple sclerosis.
Nocentini U; Bozzali M; Spanò B; Cercignani M; Serra L; Basile B; Mannu R; Caltagirone C; De Luca J
Brain Imaging Behav; 2014 Sep; 8(3):378-86. PubMed ID: 22584774
[TBL] [Abstract][Full Text] [Related]
8. Association Between Thoracic Spinal Cord Gray Matter Atrophy and Disability in Multiple Sclerosis.
Schlaeger R; Papinutto N; Zhu AH; Lobach IV; Bevan CJ; Bucci M; Castellano A; Gelfand JM; Graves JS; Green AJ; Jordan KM; Keshavan A; Panara V; Stern WA; von Büdingen HC; Waubant E; Goodin DS; Cree BA; Hauser SL; Henry RG
JAMA Neurol; 2015 Aug; 72(8):897-904. PubMed ID: 26053119
[TBL] [Abstract][Full Text] [Related]
9. Regional gray matter atrophy in relapsing remitting multiple sclerosis: baseline analysis of multi-center data.
Datta S; Staewen TD; Cofield SS; Cutter GR; Lublin FD; Wolinsky JS; Narayana PA; ;
Mult Scler Relat Disord; 2015 Mar; 4(2):124-36. PubMed ID: 25787188
[TBL] [Abstract][Full Text] [Related]
10. Comparison of grey matter atrophy between patients with neuromyelitis optica and multiple sclerosis: a voxel-based morphometry study.
Duan Y; Liu Y; Liang P; Jia X; Yu C; Qin W; Sun H; Liao Z; Ye J; Li K
Eur J Radiol; 2012 Feb; 81(2):e110-4. PubMed ID: 21316170
[TBL] [Abstract][Full Text] [Related]
11. Cognitive impairment in early MS: contribution of white matter lesions, deep grey matter atrophy, and cortical atrophy.
Engl C; Tiemann L; Grahl S; Bussas M; Schmidt P; Pongratz V; Berthele A; Beer A; Gaser C; Kirschke JS; Zimmer C; Hemmer B; Mühlau M
J Neurol; 2020 Aug; 267(8):2307-2318. PubMed ID: 32328718
[TBL] [Abstract][Full Text] [Related]
12. Localized grey matter atrophy in multiple sclerosis: a meta-analysis of voxel-based morphometry studies and associations with functional disability.
Lansley J; Mataix-Cols D; Grau M; Radua J; Sastre-Garriga J
Neurosci Biobehav Rev; 2013 Jun; 37(5):819-30. PubMed ID: 23518268
[TBL] [Abstract][Full Text] [Related]
13. Progression of regional atrophy in the left hemisphere contributes to clinical and cognitive deterioration in multiple sclerosis: A 5-year study.
Preziosa P; Pagani E; Mesaros S; Riccitelli GC; Dackovic J; Drulovic J; Filippi M; Rocca MA
Hum Brain Mapp; 2017 Nov; 38(11):5648-5665. PubMed ID: 28792103
[TBL] [Abstract][Full Text] [Related]
14. Disability-Specific Atlases of Gray Matter Loss in Relapsing-Remitting Multiple Sclerosis.
MacKenzie-Graham A; Kurth F; Itoh Y; Wang HJ; Montag MJ; Elashoff R; Voskuhl RR
JAMA Neurol; 2016 Aug; 73(8):944-53. PubMed ID: 27294295
[TBL] [Abstract][Full Text] [Related]
15. Axonal damage in spinal cord is associated with gray matter atrophy in sensorimotor cortex in experimental autoimmune encephalomyelitis.
Meyer CE; Gao JL; Cheng JY; Oberoi MR; Johnsonbaugh H; Lepore S; Kurth F; Thurston MJ; Itoh N; Patel KR; Voskuhl RR; MacKenzie-Graham A
Mult Scler; 2020 Mar; 26(3):294-303. PubMed ID: 30843756
[TBL] [Abstract][Full Text] [Related]
16. Unraveling the relationship between regional gray matter atrophy and pathology in connected white matter tracts in long-standing multiple sclerosis.
Steenwijk MD; Daams M; Pouwels PJ; J Balk L; Tewarie PK; Geurts JJ; Barkhof F; Vrenken H
Hum Brain Mapp; 2015 May; 36(5):1796-807. PubMed ID: 25627545
[TBL] [Abstract][Full Text] [Related]
17. Association of Gray Matter Atrophy Patterns With Clinical Phenotype and Progression in Multiple Sclerosis.
Rocca MA; Valsasina P; Meani A; Gobbi C; Zecca C; Rovira A; Sastre-Garriga J; Kearney H; Ciccarelli O; Matthews L; Palace J; Gallo A; Bisecco A; Lukas C; Bellenberg B; Barkhof F; Vrenken H; Preziosa P; Filippi M;
Neurology; 2021 Mar; 96(11):e1561-e1573. PubMed ID: 33441452
[TBL] [Abstract][Full Text] [Related]
18. Atrophy mainly affects the limbic system and the deep grey matter at the first stage of multiple sclerosis.
Audoin B; Zaaraoui W; Reuter F; Rico A; Malikova I; Confort-Gouny S; Cozzone PJ; Pelletier J; Ranjeva JP
J Neurol Neurosurg Psychiatry; 2010 Jun; 81(6):690-5. PubMed ID: 20392976
[TBL] [Abstract][Full Text] [Related]
19. Gray matter atrophy in multiple sclerosis: a longitudinal study.
Fisher E; Lee JC; Nakamura K; Rudick RA
Ann Neurol; 2008 Sep; 64(3):255-65. PubMed ID: 18661561
[TBL] [Abstract][Full Text] [Related]
20. Cortical atrophy patterns in multiple sclerosis are non-random and clinically relevant.
Steenwijk MD; Geurts JJ; Daams M; Tijms BM; Wink AM; Balk LJ; Tewarie PK; Uitdehaag BM; Barkhof F; Vrenken H; Pouwels PJ
Brain; 2016 Jan; 139(Pt 1):115-26. PubMed ID: 26637488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
